Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
about
Interventions for mycosis fungoidesInterventions for mycosis fungoidesRole of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphomaDenileukin diftitox for the treatment of cutaneous T-cell lymphomaOral retinoids and rexinoids in cutaneous T-cell lymphomasCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementPruritus Reduction with Systemic Anti-lymphoma Treatments in Patients with Cutaneous T Cell Lymphoma: A Narrative ReviewSystemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?T-cell Lymphoma Epidemiology: the Known and Unknown.Mycosis fungoides and Sézary syndrome: Current challenges in assessment, management and prognostic markers.Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphomaInnovative therapy of cutaneous T-cell lymphoma: beyond psoralen and ultraviolet light and nitrogen mustardCharacteristics of Cutaneous Lymphomas in Korea According to the New WHO-EORTC Classification: Report of a Nationwide StudyThe current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indicationsTranscriptional profiles predict disease outcome in patients with cutaneous T-cell lymphomaPoorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008.Diagnosis of systemic metastatic retinal lymphoma.Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosisMedical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sézary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.The Histological Spectrum of Early Mycosis Fungoides: A Study of 58 Saudi Arab patients.Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma.Sézary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-beta on the cell surfaceEvolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)Mycosis fungoides in Iranian population: an epidemiological and clinicopathological studyIL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization.Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaRomidepsin in the treatment of cutaneous T-cell lymphoma.Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registriesThe Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registriesAnalysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell linesAge, race, sex, stage, and incidence of cutaneous lymphomaPrimary cutaneous lymphomas: A clinical and histological study of 99 cases in Isfahan, Iran.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Clinically significant responses achieved with romidepsin across disease compartments in patients with cutaneous T-cell lymphomaEctopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients.Interleukin-16 as a marker of Sézary syndrome onset and stage.
P2860
Q24200749-3292FDC2-A81B-4794-A3CC-C3A7E6EC2137Q24235242-C4036D73-F90D-4AA9-821A-EB344DE814EFQ24626963-E72CD956-C29E-415E-8091-DD77E79D67E3Q24650893-ED153D78-C89C-424D-8FDA-03F8BFBA255CQ26992062-7CC5BF09-CA13-4C66-B145-02C13D9FBC21Q27024076-B6DE6AA9-0831-4323-9890-1958A226FC1CQ28075343-325ECF85-D494-4025-B11D-E4B9676E210DQ30239965-968BC1E5-81BF-4E24-A0D0-93BFBEE650B4Q30239985-CCED6288-145C-43D2-9DD0-38CFA213F6EEQ30252152-D748ADE7-8AEA-487D-8E71-91913B61BD78Q30650570-80668E51-009E-47C3-9368-887FE0CFAE1EQ33386623-99821B67-7761-4D10-8FCB-6BAEDC982C85Q33590400-6CAB2852-3C50-4468-B3A4-350C2279FC5CQ33634184-D6836971-86A4-4990-837E-A0088F6DA6E4Q33746059-3AA9900B-BEC0-46B2-950D-930180E9360BQ33783663-FC450DEB-7642-45CF-8770-9B6F6CCBC492Q33844739-CD398547-4CF3-4F29-8C2A-6EBC7350DDCAQ33940200-767D3B8B-79C6-4E97-93CB-C63F02921AA7Q34017170-D2D746CE-945C-47E5-A6C7-835B8602B3AFQ34100988-95D705B7-4EDC-42C1-B2BD-BCD1A200303FQ34137936-23D126CB-72B5-4AAD-B17F-7D9B82D00ACEQ34230614-A3BAD910-CDC5-4407-A263-4D5C159EB781Q34516083-898497DB-5F62-4966-A7A7-E0439481FCB4Q34729026-AA1A15B0-224B-4C9A-BACE-783B10C41ADEQ34754395-448B3941-8FA4-4835-BC6A-5EE25E790575Q35022833-E68BB3F4-494E-4967-8B4E-8DB3F9F5362FQ35074418-BA4FAFC5-DE7B-4ED8-9C7D-CF45ECDC6D42Q35136602-8EC82A6D-1B7B-4D55-9C78-43469844ABACQ35186682-26E42F93-7D2F-4F51-9458-E09C03558BAEQ35683831-65A06E7B-9F3D-4BC4-8A45-2A5FE321D962Q35689166-F2F5BEE3-82ED-4209-AD09-E12337455559Q35752062-FD7802CB-DFFB-4649-8D55-058C46110112Q36051812-2897906F-2637-41B4-928C-E538EBEA359FQ36187589-BD56C4D6-98C5-45E5-8BB9-230FA442CE2DQ36330634-BA36A53B-0364-499B-8CC6-EFD95AF03F39Q36417250-C39061BC-D296-4DD6-8268-26E3BDFE7EECQ36470196-1015F721-3180-4583-AD7C-3770A09B5738Q36519044-AB354BCA-07B9-4082-8065-FA957701FCD5Q36890779-A0ED18FF-1DA9-4EFF-8436-918D3BC4F594Q36890797-E3925F1B-1B3D-4680-9D6C-EC89FD65E341
P2860
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@en
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@nl
type
label
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@en
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@nl
prefLabel
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@en
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@nl
P1433
P1476
Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002.
@en
P2093
Martin A Weinstock
Vincent D Criscione
P304
P356
10.1001/ARCHDERM.143.7.854
P577
2007-07-01T00:00:00Z